People who should look elsewhere Anyone expecting semaglutide-level results
doi: 10.1111/anae.15606 [PubMed] 35131079 Walker A, Rupal A, Jani C, Al Omari O, Singh H, Patel D, Perrino C, McCannon J
Lilly is also studying Zepbound for treatment of MASH (metabolic associated steatohepatitis) and has met its goal in a Phase 2 study
Practical Monitoring Approach GLP-1 users should work with their prescribing clinician to periodically monitor: Vitamin D (25-OH-D serum level) B12 (particularly for those reducing animal protein) Complete blood count (iron status) Body composition (lean mass vs
[124] (Table S2 from Su et al., sheet S2.2 Metabolomics, age-, sex- and BMI-adjusted z-score-transformed plasma metabolite concentrations) and re-analysed the plasma metabolomics data for acetylcarnitine to investigate differences in acetylcarnitine levels between healthy controls and patients with PASC ( 1 PASC symptom according to the clinical information available from Table S1, sheet S1.3 PASC data of Su et al.)
If you injected in the evening, you are winding down and heading to bed